Debt to equity ratio has decreased and is lowest in last three years
Short term positive trend in total sale and net profit
Tremendous increasing in Book Value last 3 year
Steady View
Quarterly sales in last 5 years is trending up
Steady increase in Total Assets for last 3 Years
Company financial liquidity has improved
Risky View
Tsr Value Index - Very Poor Score of 19.44
Stock Returns < -52.34 % Than Nifty in last one year
Price to Book Ratio of 4.87 suggesting that it is very expensive
Very Low Dividend Yield of 0 %
In the last three years, the company has given poor Net Margin
In the last three years, the company has given poor Returns on Assets
Terrific Steady Risky Stock View - Fundamental Snapshot
Share Overview
Promoter Owned
40.10 %
Institution Owned
33.30 %
Public/Others
26.60 %
Outstanding Shares
11.93 Cr
Floating Shares
2.93 Cr
Floating / Outstanding
24.59%
Book Value/Share
126.53
Face value
2.00
Share Holding
Annual Key Income Statement of MEDPLUS
Period
31_Mar_2022
31_Mar_2021
Growth
Net Income From Continuing Ops
94.72
63.11
50.09 %
Net Income
95.80
63.86
50.02 %
Operating Income
86.58
73.55
17.72 %
Total Revenue
3779.28
3069.27
23.13 %
Operating Expense
3692.70
2995.72
23.27 %
Interest Expense
66.43
54.85
21.11 %
Tax Expense
23.23
31.99
27.38 %
Income Before tax
117.94
95.10
24.02 %
Gross Profit
796.90
625.75
27.35 %
Dividend Paid
0
0
%
Quarterly Key Income Statement of MEDPLUS
Period
30_Sep_2022
30_Jun_2022
Growth
Net Income From Continuing Ops
6.48
3.68
76.09 %
Net Income
6.57
3.20
105.31 %
Operating Income
17.80
14.55
22.34 %
Total Revenue
1120.63
993.65
12.78 %
Operating Expense
1060.96
979.11
8.36 %
Interest Expense
19.87
19.81
0.303 %
Tax Expense
2.35
1.19
97.48 %
Income Before tax
8.82
4.87
81.11 %
Gross Profit
242.76
210.31
15.43 %
Dividend Paid
0
0
%
Key Balance Sheet Fields
Period
31_Mar_2022
31-Mar-21
Growth
Common Stock
23.86
0.450
5202.22 %
Current Liabilities
559.01
414.94
34.72 %
Total Liabilities
1176.28
1205.91
2.46 %
Current Assets
1631.71
923.08
76.77 %
Total Assets
2594.05
1565.66
65.68 %
Working capital
1072.70
508.14
111.10 %
Accounts Payable
246.23
148.10
66.26 %
Inventory
914.98
749.96
22.00 %
Net Receivable
6.04
5.37
12.48 %
Key Cash Flow Fields
Period
31_Mar_2022
31_Mar_2021
Growth
Cash EPS
17.94
12.69
41.37 %
Cash From Investment Activity
-703.13
-34.55
1935.11 %
Cash From Financial Activity
440.43
-5.63
7922.91 %
Cash Operational Activity
169.89
2.89
5778.55 %
Net Cash Flow
-92.81
-37.29
148.89 %
NetIncome
95.80
63.86
50.02 %
Capital Expenditure
117.72
54.26
116.96 %
Change To Inventory
-165.03
-106.40
55.10 %
About Medplus Health Services Limited MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It offers pharmaceutical and wellness products, including medicines, vitamins, medical devices, and test kits; fast-moving consumer goods, such as toiletries, baby care products, soaps, detergents, and sanitizers. The company also provides wholesale cash and carry, and pathological laboratory testing services, as well as engages in the contract manufacturing of private label pharmaceuticals. As of March 31, 2021, it operated through 1,659 stores located in the states of Karnataka, Tamil Nadu, Telangana, and Andhra Pradesh, as well as through its online store. The company was incorporated in 2006 and is based in Hyderabad, India.
Address : Municipal No: 11-6-56, Hyderabad, India, 500072
TSR Tech Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is calculate from 5Mins Ticck to One Month Tick
TSR Growth analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access Growth Potential
TSR Value analyses dozen of Historical , MRQ, TTM parameters, returns of Individual Stocks vis-a-vis sector , broad based Index to access its value
This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback
We are working on fundamental strength also. Please share your views to help shape up the requirement.
